A - Kazia Therapeutics gets deficiency notice from Nasdaq November, 20 2023 04:43 PM Agilent Technologies Inc. 2023-11-20 16:43:39 ET More on Kazia Kazia issues update on paxalisib study in CNS lymphoma patients Kazia tumbles on voluntary delisting in Australia For further details see: Kazia Therapeutics gets deficiency notice from Nasdaq